Our CV-19 Antibody ‘100% Effective’ Says California Biopharma Co.
A California-based biopharmaceutical company claims to have discovered an antibody that could shield the human body from the coronavirus and flush it out of a person’s system within four days, Fox News has exclusively learned.
Later Friday, Sorrento Therapeutics will announce their discovery of the STI-1499 antibody, which the San Diego company said can provide “100{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} inhibition” of COVID-19, adding that a treatment could be available months before a vaccine hits the market.
“We want to emphasize there is a cure. There is a solution that works 100 percent,” Dr. Henry Ji, founder and CEO of Sorrento Therapeutics, told Fox News. “If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.”
This puts its arms around the virus. It wraps around the virus and moves them out of the body.”
The health care and pharmaceutical industries have been scrambling to develop viable vaccines and antibody treatments as the number of COVID-19-related deaths is expected to hit 100,000 by June 1.
Many medical researchers are scrambling to find antibodies, optimistic that they could provide a remedy or preventative care in less time than it would take to develop a vaccine. Antibody treatments have been used for the past 100 years as a means to stave off infections, but their effectiveness has had mixed results. Finding a successful antibody or convalescent plasma treatment for COVID-19 could present challenges.
Through their studies, Sorrento screened and tested billions of antibodies they have collected over the past decade. They say this made it possible to identify hundreds of potential antibody candidates that could successfully bind themselves to the spike proteins of the coronavirus. They found that a dozen of these antibodies demonstrated the ability to block the spike proteins from attaching itself to the human enzyme ACE2, which is the receptor a virus normally uses to enter human cells.
Through further testing, the researchers at Sorrento found that there was one particular antibody that showed to be 100 percent effective in blocking COVID-19 from infecting health cells — STI-1499.
“When the antibody prevents a virus from entering a human cell, the virus cannot survive,” Dr. Ji said.
Read the whole article at www.foxnews.com
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.
Trackback from your site.
Ken Hughes
| #
‘and testing for side effects?
Reply
Boris Badenov
| #
If Gates and Soros has anything to do with it, the treatment will shorten your life by 30 years and make you sterile in the process.
Reply
Charles Higley
| #
They better be careful for what they wish for. If indeed this virus is produced in the lungs, as exosomes, and simply communicable to other people once made, it means that this antibody can wipe out all exosomes, which our body needs to handle threats. The side effects should be interesting, particularly if they keep the treatment going too long. The short term should not be a problem, but suppressing this mechanism too long might prove problematic.
Reply